
570032 · 100 Tests
BDB Bioscience · Cat: 570032
Reach 3+ verified distributors
Manufacturer product page
bdbiosciences.com/en-us/products/reagents/flow-cytometry-rea...
Description
Flow cytometric analysis of IL-13 Receptor alpha2 CD213a2 expression on A-375 cells. Cells from the Human A-375 Malignant melanoma, ATCC CRL-1619 cell line were stained with either BD Horizon BV421 Mouse IgG1, kappa Isotype Control Cat. No. 562438; dashed line histogram or BD Horizon BV421 Mouse Anti-Human IL-13 Receptor alpha2 CD213a2 antibody Cat. No. 570032/570113; solid line histogram . BD Via-Probe Cell Viability 7-AAD Solution Cat. No. 555815/555816 was added to cells right before analysis. The fluorescence histogram showing IL-13 Receptor alpha2 CD213a2 expression or Ig Isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable 7-AAD-negative A-375 cells. Flow cytometry and data analysis were performed using a BD X-20 LSRFortessa Cell Analyzer System and FlowJo Software. Flow cytometric analysis of IL-13 Receptor alpha2 CD213a2 expression on A-375 cells. Cells from the Human A-375 Malignant melanoma, ATCC CRL-1619 cell line were stained with either BD Horizon BV421 Mouse IgG1, kappa Isotype Control Cat. No. 562438; dashed line histogram or BD Horizon BV421 Mouse Anti-Human IL-13 Receptor alpha2 CD213a2 antibody Cat. No. 570032/570113; solid line histogram . BD Via-Probe Cell Viability 7-AAD Solution Cat. No. 555815/555816 was added to cells right before analysis. The fluorescence histogram showing IL-13 Receptor alpha2 CD213a2 expression or Ig Isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable 7-AAD-negative A-375 cells. Flow cytometry and data analysis were performed using a BD X-20 LSRFortessa Cell Analyzer System and FlowJo Software. Show More Flow cytometric analysis of IL-13 Receptor alpha2 CD213a2 expression on A-375 cells. Cells from the Human A-375 Malignant melanoma, ATCC CRL-1619 cell line were stained with either BD Horizon BV421 Mouse IgG1, kappa Isotype Control Cat. No. 562438; dashed line histogram or BD Horizon BV421 Mouse Anti-Human IL-13 Receptor alpha2 CD213a2 antibody Cat. No. 570032/570113; solid line histogram . BD Via-Probe Cell Viability 7-AAD Solution Cat. No. 555815/555816 was added to cells right before analysis. The fluorescence histogram showing IL-13 Receptor alpha2 CD213a2 expression or Ig Isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable 7-AAD-negative A-375 cells. Flow cytometry and data analysis were performed using a BD X-20 LSRFortessa Cell Analyzer System and FlowJo Software.